Screener
Capricor Therapeutics CAPR Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Capricor Therapeutics’s 10-Q, filed November 10, 2025. Open the filing →
- Filed
- Nov 10, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001104659-25-109298
FAQ
- What is Capricor Therapeutics's operating margin?
- Capricor Therapeutics (CAPR) reported operating margin of -778.8% in Q3 2025.
- How has Capricor Therapeutics's operating margin changed year-over-year?
- Capricor Therapeutics's operating margin decreased by 400.4% year-over-year, from -155.6% to -778.8%.
- What is the long-term trend for Capricor Therapeutics's operating margin?
- Over 2 years (2020 to 2024), Capricor Therapeutics's operating margin has grown at a -79.2% compound annual growth rate (CAGR), from -4,412.6% to -191.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Capricor Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude